Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes | Zendy

Michelle L. O’Donoghue | Zendy; James A. de Lemos | Zendy; David A. Morrow | Zendy; Sabina A. Murphy | Zendy; Jacqueline L. Buros | Zendy; Christopher P. Can | Zendy; Marc S. Sabatine | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes

Author(s) -

Michelle L. O’Donoghue,

James A. de Lemos,

David A. Morrow,

Sabina A. Murphy,

Jacqueline L. Buros,

Christopher P. Can,

Marc S. Sabatine

Publication year - 2006

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.106.641936

Subject(s) - medicine , heart type fatty acid binding protein , myocardial infarction , cardiology , timi , heart failure , hazard ratio , acute coronary syndrome , troponin , creatinine , proportional hazards model , fatty acid binding protein , troponin t , percutaneous coronary intervention , confidence interval , chemistry , gene , biochemistry

Heart-type fatty acid binding protein (H-FABP) is a cytosolic protein that is released rapidly from the cardiomyocyte in response to myocardial injury. Although it has been investigated as an early marker of acute myocardial infarction, its prognostic utility in acute coronary syndromes has not been established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research